DailyDoctor Archive Specialties Get app
All ent & head and neck surgery briefings

The edition · ENT & Head and Neck Surgery

Two hearing aids beat one for age-related loss, but not by a clear margin

A randomised trial of 275 adults found bilateral fitting gave more self-reported benefit than unilateral, with both clearly helping. Also: where VTE risk concentrates in ENT surgery, cannabis and opioid use after free flaps, and cryotherapy for chronic rhinitis.

The edition in brief

A single-blinded randomised trial at two US centres assigned 275 adults aged 50 or over with age-related hearing loss and little prior hearing aid use to one or two receiver-in-the-canal aids. Both groups improved on the Abbreviated Profile of Hearing Aid Benefit at three months; bilateral fitting gave about 5 points more benefit (95% CI 1.8 to 8.8), a statistically clear difference that the authors say may not be clinically meaningful. A US database study of 277,187 ENT operations found 90-day venous thromboembolism in 0.63% overall, but 6.1% after free tissue transfer, 4.4% after lateral skull base surgery and 3.1% after cricopharyngeal myotomy and anterior skull base surgery, with prior VTE the strongest risk factor. A matched cohort of 1,064 head and neck free flap patients found preoperative cannabis use associated with more prolonged opioid use and gastrostomy dependence. A 354-patient industry device registry reported symptom improvement in about three-quarters of people after nasal cryotherapy for chronic rhinitis, without serious adverse events, but had no control group.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for ent & head and neck surgery, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free